Clinical trial · Interventional
The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery
The Effectiveness of a Mobile Lung Rehabilitation System on Patient Satisfaction and Lung Function After Lung Cancer Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to investigate the effect of a mobile application intervention on postoperative lung rehabilitation. The main purposes of this study are: 1. To understand the effectiveness of the pulmonary rehabilitation mobile application in improving lung function. 2. To assess the feasibility of the pulmonary rehabilitation mobile application in post-surgery rehabilitation care. Researchers will compare the intervention group (using the pulmonary rehabilitation mobile application) to the usual care group to determine if the mobile application is effective in lung surgery rehabilitation. Participants will join the study immediately after providing informed consent and will continue for up to 7 weeks post-surgery. Participants will be randomly allocated to either the intervention group or the control group. Both groups will receive regular pulmonary rehabilitation during their hospital stay (1 day before surgery and 2 to 3 days after surgery). Researchers will guide participants in the intervention group to use the mobile application for pulmonary rehabilitation exercises throughout the study period. Participants in the usual care group will receive health education and an exercise guide before discharge. Participants will undergo three study assessments: at baseline (within 1 week after enrollment), post-surgery (week 5), and at follow-up (week 8).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Pulmonary Rehabilitation | — | UNRESOLVED | — |
| Telerehabilitation | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Healthcare interactive Web Platform | Other | — | UNRESOLVED |
| Lung cancer postoperative standard care | Behavioral | — | UNRESOLVED |
| RehabLung mobile application | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- application inttervention group
- description
- The experimental group will receive standard postoperative care, including chest rehabilitation, a mobile application for remote self-training every day after surgery, and an interactive healthcare web platform for health education.
- interventionNames
- Behavioral: RehabLung mobile application
- Other: Healthcare interactive Web Platform
- type
- ACTIVE_COMPARATOR
- label
- Usual care group
- description
- The usual care group will receive standard postoperative care, including chest rehabilitation and an interactive healthcare web platform for health education
- interventionNames
- Behavioral: Lung cancer postoperative standard care
- Other: Healthcare interactive Web Platform
Primary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * age over 20 years * primary diagnosis of lung cancer at any stage and type * referral to lung cancer resection by thoracotomy or videothoracoscopy * ability to understand and consent to the trial procedures * conscious and cognition intact Exclusion Criteria: * included adjuvant treatments (chemotherapy or radiotherapy) * previous history of thoracic surgery * neurological and/or musculoskeletal comorbidities * visual or hearing impairment * acute respiratory illness
References
Publications (1)
- DERIVEDYang HL, Hung CH, Huang YT, Cheng HC, Tseng YL, Su JM, Tsai KL. The effectiveness of the AI-based RehabLung mobile rehabilitation system on cardiopulmonary function and user satisfaction in lung cancer patients undergoing thoracic surgery: a protocol for a two-arm randomized clinical trial. Ther Adv Respir Dis. 2026 Jan-Dec;20:17534666261427319. doi: 10.1177/17534666261427319. Epub 2026 Feb 28. PMID 41762649